Swiss National Bank Zynex Inc Transaction History

Swiss National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$6.95 - $9.89 $31,275 - $44,505	4,500 Added 10.25%	48,400 $387,000
Q2 2023 Aug 09, 2023	SELL	$8.59 - $14.56 $39,514 - $66,976	-4,600 Reduced 9.48%	43,900 $421,000
Q1 2023 May 10, 2023	BUY	$9.53 - $16.8 $462,204 - $814,800	48,500 New	48,500 $582,000
Q2 2022 Aug 09, 2022	SELL	$5.78 - $8.87 $313,911 - $481,729	-54,310 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.14 - $9.35 $42,199 - $76,763	8,210 Added 17.81%	54,310 $338,000
Q2 2021 Aug 06, 2021	BUY	$12.25 - $14.87 $35,525 - $43,123	2,900 Added 6.71%	46,100 $716,000
Q4 2020 Feb 05, 2021	BUY	$11.65 - $17.94 $29,125 - $44,850	2,500 Added 6.14%	43,200 $581,000
Q2 2020 Aug 05, 2020	BUY	$9.06 - $23.49 $368,742 - $956,042	40,700 New	40,700 $1.01 Million

110

9.04M

31.4K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $306M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.